Shares of Ampio Pharmaceuticals (NYSEMKT:AMPE) fell in Friday’s pre-market session, after the biopharmaceutical company priced a public offering of 8.5 million shares at $7 per share, a 12% discount to the stock’s Thursday closing price. The shares were off 6.2% at $7.45 in recent pre-market trading. They have a 52-week range of $3.75 to $10.86….
Dril-Quip, Inc. (NYSE:DRQ), which makes engineered offshore drilling and production equipment, said net income rose to $47.1 million, or $1.15 per diluted share, from $31.0 million, or $0.76 per diluted share, beating analysts’ estimates by one cent, according to Capital IQ. The company said the Q4 results for 2013 results were hit by an after-tax…
Shares of J.C. Penney Company, Inc. (NYSE:JCP) have soared almost 27% in pre-market trade to $7.55 after the company reported Q4 results during yesterday’s after-hours session that topped analyst expectations. JCP reported earnings per share losses of $0.68 for the quarter, compared to analyst forecasts of losses of $0.76 per share. The retailer also reported…
Huntington Ingalls Industries (NYSE:HII) reported Q4 earnings that were well ahead of analysts’ estimates. The ship- and submarine builder said its adjusted diluted earnings rose nearly 28% to $1.66, exceeding the $1.22 average estimate from analysts polled by Capital IQ, if comparable. On a non-adjusted basis, diluted net earnings rose to $91 million from $50…
Specialty foundry company Tower Semiconductor Ltd. (NASDAQ:TSEM) reports non-GAAP diluted EPS of $0.34 for Q4 2013, up sequentially from $0.22 in Q3 2013. Two analysts surveyed by Capital IQ called for non-GAAP diluted EPS of $0.29. Revenue was down 2% from Q3 2013 to $134.6 million, falling short of the $140 million Capital IQ consensus….
Energy company Delek US Holdings, Inc. (NYSE:DK) reported Wednesday night Q4 2013 net loss of $4.7 million, or $0.08 per share, compared to a net income of $64.3 million, or $1.06 per share, a year earlier. Adjusted earnings were not provided, which would have been comparable to the Capital IQ consensus of $0.11. Net sales…
